{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Selinexor  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Selinexor. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Selinexor  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "selinexor",
    "trial_2_text": "Selinexor  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Selinexor Supplement: 60 participants will take Selinexor 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Selinexor. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Selinexor  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.39351561665534973,
      "78": 0.31718671321868896,
      "189": 0.25197669863700867,
      "123": 0.24159424006938934,
      "20": 0.2315966933965683,
      "188": 0.2168404906988144,
      "17": 0.21154426038265228,
      "228": 0.20904816687107086,
      "173": 0.20245173573493958,
      "9": 0.19372281432151794,
      "37": 0.18492382764816284,
      "177": 0.18439003825187683,
      "67": 0.1836598515510559,
      "21": 0.1790177971124649,
      "64": 0.1575634777545929,
      "2": 0.15232959389686584,
      "68": 0.15205931663513184,
      "49": 0.14434950053691864,
      "46": 0.14389368891716003,
      "350": 0.14203138649463654,
      "77": 0.1385977566242218,
      "200": 0.1296151876449585,
      "239": 0.1261948198080063,
      "29": 0.12192622572183609,
      "14": 0.12150846421718597,
      "193": 0.11578916013240814,
      "243": 0.1157788559794426,
      "79": 0.11448359489440918,
      "101": 0.1108846664428711,
      "126": 0.10343272238969803,
      "104": 0.10106882452964783,
      "194": 0.09779512137174606,
      "261": 0.09760554134845734,
      "72": 0.09589793533086777,
      "38": 0.0953197106719017,
      "191": 0.09511110931634903,
      "179": 0.09469779580831528,
      "76": 0.0945490151643753,
      "86": 0.09166721254587173,
      "114": 0.09042331576347351,
      "131": 0.08858109265565872,
      "27": 0.08549358695745468,
      "30": 0.08467923104763031,
      "85": 0.08340668678283691,
      "5": 0.08177090436220169,
      "396": 0.08115119487047195,
      "102": 0.08007284998893738,
      "180": 0.07952123135328293,
      "288": 0.07837346941232681,
      "116": 0.0778692364692688,
      "82": 0.07544078677892685,
      "355": 0.07390180230140686,
      "35": 0.07304909825325012,
      "151": 0.07294090837240219,
      "61": 0.07292994111776352,
      "249": 0.07216702401638031,
      "204": 0.06932904571294785,
      "122": 0.06839856505393982,
      "139": 0.06742487102746964,
      "147": 0.0667639747262001,
      "269": 0.06515886634588242,
      "28": 0.06462995707988739,
      "130": 0.06382958590984344,
      "441": 0.06358402967453003,
      "18": 0.062616266310215,
      "282": 0.0625467449426651,
      "341": 0.0620805062353611,
      "234": 0.06110629811882973,
      "144": 0.060512300580739975,
      "36": 0.05993428826332092,
      "466": 0.05985071882605553,
      "33": 0.059411417692899704,
      "136": 0.0585705041885376,
      "186": 0.058242302387952805,
      "276": 0.05707184597849846,
      "253": 0.056983832269907,
      "286": 0.05524848401546478,
      "69": 0.05449657887220383,
      "454": 0.054167717695236206,
      "361": 0.053629714995622635,
      "212": 0.052617691457271576,
      "96": 0.052330028265714645,
      "1": 0.05211566761136055,
      "356": 0.05170028284192085,
      "4": 0.048660676926374435,
      "132": 0.04850098490715027,
      "422": 0.04849075525999069,
      "154": 0.04809729754924774,
      "382": 0.04767465591430664,
      "257": 0.04753415286540985,
      "142": 0.04709382727742195,
      "97": 0.046932391822338104,
      "211": 0.04603802040219307,
      "98": 0.04563729465007782,
      "164": 0.044981904327869415,
      "75": 0.044957924634218216,
      "256": 0.04464547708630562,
      "92": 0.044445060193538666,
      "262": 0.04382379353046417,
      "339": 0.043265361338853836
    },
    "trial_2_ae": {
      "87": 0.39351561665534973,
      "78": 0.31718671321868896,
      "189": 0.25197669863700867,
      "123": 0.24159424006938934,
      "20": 0.2315966933965683,
      "188": 0.2168404906988144,
      "17": 0.21154426038265228,
      "228": 0.20904816687107086,
      "173": 0.20245173573493958,
      "9": 0.19372281432151794,
      "37": 0.18492382764816284,
      "177": 0.18439003825187683,
      "67": 0.1836598515510559,
      "21": 0.1790177971124649,
      "64": 0.1575634777545929,
      "2": 0.15232959389686584,
      "68": 0.15205931663513184,
      "49": 0.14434950053691864,
      "46": 0.14389368891716003,
      "350": 0.14203138649463654,
      "77": 0.1385977566242218,
      "200": 0.1296151876449585,
      "239": 0.1261948198080063,
      "29": 0.12192622572183609,
      "14": 0.12150846421718597,
      "193": 0.11578916013240814,
      "243": 0.1157788559794426,
      "79": 0.11448359489440918,
      "101": 0.1108846664428711,
      "126": 0.10343272238969803,
      "104": 0.10106882452964783,
      "194": 0.09779512137174606,
      "261": 0.09760554134845734,
      "72": 0.09589793533086777,
      "38": 0.0953197106719017,
      "191": 0.09511110931634903,
      "179": 0.09469779580831528,
      "76": 0.0945490151643753,
      "86": 0.09166721254587173,
      "114": 0.09042331576347351,
      "131": 0.08858109265565872,
      "27": 0.08549358695745468,
      "30": 0.08467923104763031,
      "85": 0.08340668678283691,
      "5": 0.08177090436220169,
      "396": 0.08115119487047195,
      "102": 0.08007284998893738,
      "180": 0.07952123135328293,
      "288": 0.07837346941232681,
      "116": 0.0778692364692688,
      "82": 0.07544078677892685,
      "355": 0.07390180230140686,
      "35": 0.07304909825325012,
      "151": 0.07294090837240219,
      "61": 0.07292994111776352,
      "249": 0.07216702401638031,
      "204": 0.06932904571294785,
      "122": 0.06839856505393982,
      "139": 0.06742487102746964,
      "147": 0.0667639747262001,
      "269": 0.06515886634588242,
      "28": 0.06462995707988739,
      "130": 0.06382958590984344,
      "441": 0.06358402967453003,
      "18": 0.062616266310215,
      "282": 0.0625467449426651,
      "341": 0.0620805062353611,
      "234": 0.06110629811882973,
      "144": 0.060512300580739975,
      "36": 0.05993428826332092,
      "466": 0.05985071882605553,
      "33": 0.059411417692899704,
      "136": 0.0585705041885376,
      "186": 0.058242302387952805,
      "276": 0.05707184597849846,
      "253": 0.056983832269907,
      "286": 0.05524848401546478,
      "69": 0.05449657887220383,
      "454": 0.054167717695236206,
      "361": 0.053629714995622635,
      "212": 0.052617691457271576,
      "96": 0.052330028265714645,
      "1": 0.05211566761136055,
      "356": 0.05170028284192085,
      "4": 0.048660676926374435,
      "132": 0.04850098490715027,
      "422": 0.04849075525999069,
      "154": 0.04809729754924774,
      "382": 0.04767465591430664,
      "257": 0.04753415286540985,
      "142": 0.04709382727742195,
      "97": 0.046932391822338104,
      "211": 0.04603802040219307,
      "98": 0.04563729465007782,
      "164": 0.044981904327869415,
      "75": 0.044957924634218216,
      "256": 0.04464547708630562,
      "92": 0.044445060193538666,
      "262": 0.04382379353046417,
      "339": 0.043265361338853836
    }
  },
  "safety": {
    "trial_1_safety": 0.44779613614082336,
    "trial_2_safety": 0.44779613614082336
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.480285108089447
  }
}